Fungicidal effect and oral acute toxicity of Psophocarpus tetragonolobus root extract

Pharmaceutical Biology

Volumn 46, Issue 4, 2008, Pages 261-265

  Sasidharan, S ^a,b   Zuraini, Z ^a   Latha, L Yoga ^a   Suryani, S ^a  

^a SCHOOL OF PHYSICS   (Malaysia)

^b AIMST UNIVERSITY   (Malaysia)

Author keywords

C. albicans; Fungicidal activity; P. tetragonolobus root; Plant extract

Indexed keywords

MICONAZOLE NITRATE; PLANT EXTRACT; PSOPHOCARPUS TETRAGONOLOBUS EXTRACT; UNCLASSIFIED DRUG;

ACUTE TOXICITY; ANIMAL EXPERIMENT; ANTIMICROBIAL ACTIVITY; ARTICLE; AUTOPSY; CANDIDA ALBICANS; CONTROLLED STUDY; DRUG EFFECT; DRUG EXPOSURE; FEMALE; FUNGAL MORPHOLOGY; FUNGICIDAL ACTIVITY; FUNGUS GROWTH; LEGUME; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PLANT ROOT; PSOPHOCARPUS TETRAGONOLOBUS; RAT; SCANNING ELECTRON MICROSCOPY; YEAST CELL;

CANDIDA ALBICANS; FABACEAE; PSOPHOCARPUS TETRAGONOLOBUS; RATTUS;

EID: 41349112135     PISSN: 13880209     EISSN: 17445116     Source Type: Journal    
DOI: 10.1080/13880200701740858     Document Type: Article

References (13)

1. Bagg J, Sweeney MP, Lewis MA, Jackson MS, Coleman D, Baxter W, McEndrick S, McHugh S (2003): High prevalence of nonalbicans yeasts and detection of anti-fungal resistance in the oral flora of patients with advanced cancer. Palliat Med 17: 477-481.
2. Baquero F (1997): Gram-positive resistance: Challenges for the development of new antibiotics. J Antimicrob Chemother 39: 1-6.
3. Borgers M, Van De Ven MA, Van Cutsen J (1989): Structural degeneration of Aspergillus fumigatus after exposure to saperconazole. J Med Vet Mycol 27: 381-389.
4. Burkill IH (1935): Dictionary of the Economic Products of the Malay Peninsula, 2nd ed. Edited by Ministry of Agriculture (Malaysia), London, Crown Agents for the Colonies, p. 2402.
5. Chopra I, Hodgson J, Metcalf B, Poste G (1996): New approaches to the control of infections caused by antibiotic resistant bacteria. An industry perspective. JAMA 275: 401-403.
6. Eggimann P, Garbino J, Pittet D (2003) Management of Candida species infections in critically ill patients. Lancet Infect 3: 772-785.
7. Jarvis WR (1995): Epidemiology of nosocomial fungal infections, with emphasis on Candida species. Clin Infect 20: 1526-1530.
8. NCCLS (National Committee for Clinical Laboratory Standards) (2002): Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically, 3rd ed. Approved standard. NCCLS document M100-S12. Wayne, PA, NC-275 CLS.
9. NCID (National Center for Infectious Diseases) (2002): Campaign to Prevent Antimicrobial Resistance in Healthcare Settings. Centre for Disease Control and Prevention. Available at http://www.cdc.gov/drugresistacne/ healthcare/problem.htm.
10. OECD (Organization for Economic Cooperation and Development) (2000): Guidelines for the Testing of Chemicals, Revised Draft Guideline: Acute Oral Toxicity. France, OECD, p. 423.
11. Perry LM (1980): Medicinal Plants of East and Southeast Asia. Cambridge, MA, The MIT Press, p. 231.
12. Stopp K (1962): The medicinal used by the Mt. Hagen people (mbowamb) in New Guinea. Econ Bot 17: 16-22.
13. Yoga Latha L, Sasidharan S, Zuraini Z, Saravanan D, Suryani S, Sangetha S, Siti Aishah MB (2005): Antioxidant properties of Psophocarpus tetragonolobus. J Trop Med Plants 6: 173-177.